ABSTRACT
chronic pancreatitis. [3] Management of PPs has traditionally included a period of observation from 4 to 6 weeks, allowing the cystic wall to mature. Therapeutic modalities include endoscopic and radiologic intervention, as well as surgical approach. Selection of modality depends upon the etiology, location, size, and clinical course of the pseudocyst. [4] Recent studies have suggested that spontaneous resolution can be safely and effectively achieved in up to 86% of patients if longer periods of observation are employed. Serious complications may develop in only 3-9% of cases during an averaged 1-year expectant follow-up. [4, 5] In the present study, a scoring system designed to predict spontaneous resolution of PPs was developed.
MATERIALS AND METHODS
The present was an observational cohort study. 
INTRODUCTION
In the revised Atlanta classification, local complications of acute pancreatitis are defined as acute peripancreatic fluid collections, pancreatic pseudocysts, acute pancreatic or peripancreatic necrotic collections, and walled-off necrosis. [1] Pancreatic pseudocysts and peripancreatic fluid collections are the most commonly reported clinical manifestations. [2] Pancreatic pseudocysts (PPs) are defined as fluid collections with no or minimal solid components, surrounded by a nonepithelial wall of fibrous or granulated tissue, arising as a consequence of acute pancreatitis. [1] Incidence ranges from 5% to 16% and is reported to be higher in patients with underlying Şenol et al. Can outcome of pancreatic pseudocysts be predicted? Proposal for a new scoring system taken from the Atlanta classification. Patients who received primary treatment at another hospital and those misclassified were excluded.
Sixty-eight of the initial 70 patients fulfilled the criteria for true PPs, with the exception of postnecrotic collections that constituted walled-off necrosis formation.
Etiology was considered to be of biliary origin when gallstones were found on radiologic examination. Alcohol was registered as the etiological factor when there was history of alcohol abuse. In the absence of gallstones or alcohol abuse, the etiology was considered to be other, or unknown.
Treatments offered were conservative management, percutaneous puncture and/or drainage, and surgery (e.g. internal drainage with cystogastrostomy or cystojejunostomy and resection). Percutaneous puncture and drainage procedures were performed with guidance of ultrasound or computed tomography.
Independent Variables
Demographic data and the following laboratory measurements were obtained from each patient record: serum amylase, white blood cell count, platelets, hematocrit, calcium, blood glucose, creatinine, blood urea nitrogen, total/direct bilirubin, alkaline phosphatase (AP), lactate dehydrogenase, γ-glutamyl transferase, alanine aminotransferase, aspartate aminotransferase, cyst diameter, and cyst fluid carcinoembryonic antigen (CEA) level.
Dependent Variable
Primary endpoint was spontaneous resolution of PPs, including partial and complete resolution, with uneventful followup.
Statistical Analysis
Continuous data were presented as mean±SD, and differences between groups were analyzed with Mann-Whitney U test. Shapiro-Wilk test was used to assess normality. Categorical variables were analyzed with χ 2 tests. Logistic regression was used to identify variables associated with spontaneous resolution. To calculate scores, a logistic regression model was developed, in which presence of spontaneous resolution was the dependent variable, and clinical and pathologic variables were considered to be numerical or categorical covariates.
The final model generated a set of independent prognostic variables with β regression coefficients, standard error (SE) of coefficients, and p values. The fit of the model was verified by the Hosmer-Lemeshow goodness-of-fit test. Clinical scores were based on the final logistic regression model. Model discrimination was determined by measuring by the area under the receiver operating characteristic (ROC) curve (AUC). Discrimination of a prognostic model is considered to be perfect if AUC=1, good if AUC >0.8, moderate if AUC is 0.6-0.8, and poor if AUC <0.6.
RESULTS
Mean (SD) age of patient population was 56.6 (16.7) years, and female:male ratio was 1.34:1. Causes of pancreatitis were stones (48.5%), alcohol (26.5%), and unknown (25%). The most common symptom associated with the complicated clinical course of the disease was abdominal pain (in 42 patients, 61.7%).
Mean size of pseudocyst was 71±54 mm (range: 8-240 mm). PPs were located around the head of the pancreas in 42 patients (61.8%), and in the body or tail of the pancreas in 26 patients (28.2%). Demographic characteristics are shown in Table 1 . , and cyst diameters (>55 mm) were found to be significantly different between patients with and without spontaneous resolution. With multivariate analysis, the same variables were found to be statistically significant (Table 2) . Scores were calculated by assigning points to these variables. In spite of differences in regression coefficients, which ranged from 1.2 to 2.9, for the sake of simplicity, 1 point was assigned for cyst diameter (>55 mm), 2 points were assigned for cyst CEA level (>1.5), and 1 point was assigned for serum direct bilirubin level (>0.95 mg/dL). The resulting score ranged from 0 to 4.
Four groups of patients were identified, based on score. The first group (score 1) had a spontaneous resolution rate of 91.7%, comprised approximately 17.9% of the cohort, and included patients with 0 points. The second group (score 2) had a spontaneous resolution rate of 56.5%, comprised approximately 34.3% of the cohort, and included patients with 1 point. The third group (score 3) had a spontaneous resolution rate of 35.7%, comprised approximately 20.9% of the cohort, and included patients with 2 points. Spontaneous resolution rates were 16.7% and 0% for patients with 3 and 4 points, respectively (score 4). Rates are displayed in Table 3 .
The Hosmer-Lemeshow goodness-of-fit test of the final model was p=0.961, indicating a quite adequate fit of the model to the data. AUC of the new score was 0.789 (0.682 to 0.896).
DISCUSSION
Primary treatment modality of PPs involves conservative approaches until the PPs become asymptomatic. [6] Recent studies have concluded that 8-86% of PPs resolve spontaneously, while 5-15% of collections form symptomatic mature pseudocysts. [7] During an averaged 1-year expectant follow-up, 3-9% of mature PPs presented with serious complications, including infection, bleeding, and jaundice. [4] PPs larger than 6 cm are closely correlated with increased risk of complication. [5] It has been demonstrated in a majority of related studies that PPs larger than 5 or 6 cm have lower rates of spontaneous resolution. [8] [9] [10] [11] Authors have emphasized that, depending on size, early operation or drainage of pseudocyts improves rates of morbidity and mortality. [12] Therefore, it is strongly suggested that surgical or percutaneous drainage be considered in cases of PPs larger than 6 cm. [6] While data regarding PP size and clinical course varies between studies, cysts smaller than 4 cm are considered to be independent factors for spontaneous resolution and favorable outcome. [4, 13] In the present study, 47% of PPs showed uneventful partial or complete resolution during early stages of follow-up (mean: 15±11.55 months). Significant differences in cyst diameter were found between the resolution and intervention groups (35±9 mm vs 71±8 mm, p=0.004). More complicated clinical courses were observed in the intervention group, related to increased PP size. Both univariate and multivariate analysis demonstrated that cyst diameter <53 mm was a predictive factor for spontaneous resolution. Differences in cyst diameter among groups indicated that percutaneous intervention and/or surgical treatment must be considered as treatment options for larger PPs, in accordance with the literature. [14] In addition, Nguyen et al. demonstrated similar results regarding rates of spontaneous resolution, intervention, recurrence, and mortality in PPs larger or smaller than 6 cm. The authors concluded that etiology of AP is a more efficient means of predicting clinical outcome than cyst size. [15] Thus, pseudocyst size is not a significant indicator of spontaneous resolution, requiring more efficient parameters for the prediction of eventual outcome.
PPs comprise 75% of pancreatic cysts. History of unnoticed acute pancreatitis renders distinction between cystic neoplasms, retention cysts, congenital cysts, and pseudocysts difficult until intervention is performed. [16] In a clinical setting, data obtained from cyst fluid informs the differential diagnosis of a pseudocyst. No remarkable literature regarding biological predictive factors for spontaneous resolution of PPs could be found. Complicated clinical course of PPs and practical manifestation of serum markers should lead clinicians to consider the option of medical therapy. Several studies have shown that cyst fluid analysis with elevated amylase in the thousands and low CEA level (<192 ng/mL) supports the diagnosis of a pseudocyst and helps determine the optimal therapeutic strategy by excluding pancreatic cystic malignancies. [17] [18] [19] Cyst fluid may contain acute and chronic inflammatory cells, histiocytes, and macrophages. [20] Only complicated cases with gastrointestinal epithelial and mucin contamination, particularly from the stomach, should include cystic lining epithelial cells. [19, 21, 22] Van der Waaij et al. analyzed 12 studies and demonstrated that CEA levels below 5 ng/mL present a specificity of 95% for pseudocyst formation. [18] Biliary complications of PPs manifest as obstructive jaundice, requiring intervention until the pseudocyst resolves. Jaundice may result from distortion and narrowing of the intra-pancreatic segment of the common bile duct by progressive fibrosis of the pancreatic tissue, as exhibited in cases of chronic pancreatitis (or rarely by compression of the duct by a pseudocyst). [23, 24] In the present study, cyst fluid CEA mean levels were significantly lower in the resolution group than in the intervention group (1.59±1.53 ng/mL vs 2.36±1.46 ng/mL, p=0.002). This indicated a correlation between higher levels of CEA and complicated clinical course of disease. When CEA levels did not indicate malignancy, pseudocyst fluid levels with CEA>1.5 ng/ mL demonstrated inverse predictive power of spontaneous resolution. In addition, 21 patients (32.3%) had symptoms of jaundice, while only 4 (5.8%) responded well to conservative treatment. Serum direct bilirubin levels of the resolution group were significantly lower than those of the intervention group (1.07±0.97 mg/dL vs 2.32±1 mg/dL, p=0.004). In both univariate and multivariate analyses, elevation of direct bilirubin levels higher than 0.95 mg/dL were closely correlated with surgical or percutaneous intervention and lower rates of resolution.
In routine practice, asymptomatic PPs are safely observed, depending on size and location of cyst and secondary complications. Treatment algorithms and indications for therapeutic intervention were primarily developed according to challenges faced in the management of the disease. Therefore, accurate and effective prognostic scoring systems are essential to prevent characteristic complications of PPs and attendant therapeutic challenges.
Conclusion
A scoring system based on cyst diameter, serum direct bilirubin, and cyst CEA level was developed in the present study. This system is simple and employs routinely collected radiologic and laboratory parameters. PPs with cyst diameter <53 mm, cyst fluid CEA level <1.5 ng/mL, and serum direct bilirubin level <0.9 mg/dL have high tendency to spontaneously resolve. PPs with scores of 3 and 4 are complicated, with unfavorable clinical outcomes. Adverse outcome and prolonged follow-up should be reduced by applying this scoring system during management of the disease in a clinical setting. The present retrospective cohort study requires validation with prospective randomized clinical studies.
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